What Women's Health Foundry is
Women's Health Foundry is specialist infrastructure being developed to help selected women's health innovations move from research toward de-risked, investment-ready ventures, with stage-appropriate support across evidence sequencing, venture milestones, and ecosystem connections.
Women's health is not just underfunded. It is under-translated. The core problem is a structural gap between discovery and the expertise, capital, and commercial pathways needed to reach patients. This platform is designed to close that gap.
It is built for credibility with founders, researchers, universities, clinicians, industry, investors, and government-adjacent stakeholders: serious, institutional, high-trust, and operator-led.
Proto Axiom
Proto Axiom is the builder-operator: it designs and runs the platform's operating model, milestone logic, partner alignment, and execution. Not passive capital or arm's-length sponsorship.
Women's Health Foundry uses a distinct public identity because institutions, clinicians, and investors need clarity on governance and independence. The platform is being developed with academic, clinical, consumer, industry, and investor partners.
Track record
Proto Axiom is a company creator — the first investor into university spinouts, taking large equity stakes and providing active incubation with a 30-person pharma-grade operations team. The Women's Health Foundry operating model draws directly on this infrastructure.
8
Portfolio companies created from Australian university science
A$45M
Capital raised across 33 institutional and individual investors
4+
University partnerships (USyd, UNSW, Griffith, UoW)
30
Team members across investment, operations, and science
Disclaimer
Women's Health Foundry is a platform in development. Features, eligibility, timelines, and partnership models are subject to final settings and approvals. Nothing on this site constitutes medical, legal, tax, or investment advice or an offer to fund, partner with, or admit any person or organisation.